serrawettin W2: extracellular cyclic lipopeptide which promotes flagellum-dependent & -independent spreading growth of Serratia marcescens; amino acid sequence given in first source
ID Source | ID |
---|---|
PubMed CID | 164436 |
MeSH ID | M0198718 |
Synonym |
---|
serrawettin w2 |
140909-80-4 |
(3s,6r,12s,15r)-6-benzyl-3-[(2s)-butan-2-yl]-19-heptyl-9-[(1r)-1-hydroxyethyl]-12-(hydroxymethyl)-15-(2-methylpropyl)-1-oxa-4,7,10,13,16-pentazacyclononadecane-2,5,8,11,14,17-hexone |
l-isoleucine, n-(n-(n-(n-(n-(3-hydroxy-1-oxodecyl)-d-leucyl)-l-seryl)-l-threonyl)-d-phenylalanyl)-, rho-lactone |
DTXSID10930940 |
6-benzyl-3-(butan-2-yl)-19-heptyl-5,8,11,14,17-pentahydroxy-9-(1-hydroxyethyl)-12-(hydroxymethyl)-15-(2-methylpropyl)-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13,16-pentaen-2-one |
Serrawettin W2 was shown to be a novel cyclodepsipeptide containing a fatty acid (3-hydroxydecanoic acid) and five amino acids.
Excerpt | Reference | Relevance |
---|---|---|
"Serrawettin W2 was shown to be a novel cyclodepsipeptide containing a fatty acid (3-hydroxydecanoic acid) and five amino acids." | ( A novel extracellular cyclic lipopeptide which promotes flagellum-dependent and -independent spreading growth of Serratia marcescens. Hara-Hotta, H; Isa, K; Kaneda, K; Matsuyama, T; Nakagawa, Y; Yano, I, 1992) | 1 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (30.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 4 (40.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (10.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (90.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |